Answer
Although no specific interaction studies have been performed, Amphotericin B SUN Pharma liposomal with flucytosine may increase flucytosine toxicity, possibly through increased cellular uptake and/or impaired renal excretion, requiring an individual benefit–risk assessment.
Sources for this answer
- Amphotericin B SUN Pharma liposomal 50 mg powder for dispersion for infusionRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked